AULT MILTON C III 13D and 13G filings for Alzamend Neuro, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-11-15 4:30 pm Purchase | 2022-11-11 | 13D | Alzamend Neuro, Inc. ALZN | AULT MILTON C III | 32,460 43.200% | 1,077 (+3.43%) | Filing |
| 2022-04-28 07:00 am Purchase | 2022-04-26 | 13D | Alzamend Neuro, Inc. ALZN | AULT MILTON C III | 31,384 43.200% | 2,301 (+7.91%) | Filing |
| 2021-08-04 09:35 am Purchase | 2021-07-30 | 13D | Alzamend Neuro, Inc. ALZN | AULT MILTON C III | 29,083 42.300% | 89 (+0.31%) | Filing |
| 2021-06-25 4:30 pm Purchase | 2021-06-14 | 13D | Alzamend Neuro, Inc. ALZN | AULT MILTON C III | 28,994 41.600% | 28,994 (New Position) | Filing |